BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11036103)

  • 1. After 40 years, mammography remains as much emotion as science.
    Randal J
    J Natl Cancer Inst; 2000 Oct; 92(20):1630-2. PubMed ID: 11036103
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of efficacy of mammographic screening for women in their forties.
    Dupont WD
    Cancer; 1994 Aug; 74(4):1204-6. PubMed ID: 8055438
    [No Abstract]   [Full Text] [Related]  

  • 3. A question that will not go away: at what age should mammographic screening begin?
    Forrest AP; Alexander FE
    J Natl Cancer Inst; 1995 Aug; 87(16):1195-7. PubMed ID: 7563158
    [No Abstract]   [Full Text] [Related]  

  • 4. British trial aims to settle mammography questions.
    Reynolds T
    J Natl Cancer Inst; 1995 Mar; 87(5):338-41. PubMed ID: 7853413
    [No Abstract]   [Full Text] [Related]  

  • 5. Biology and cost-benefit in mammography screening.
    Rutqvist LE
    Acta Oncol; 1997; 36(7):673-4. PubMed ID: 9490081
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammography and beyond: building better breast cancer screening tests.
    Wang L
    J Natl Cancer Inst; 2003 Mar; 95(5):344-6. PubMed ID: 12618493
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammography screening for breast cancer. Reply to the commentaries.
    Kopans DB; Halpern E; Hulka CA
    Cancer; 1994 Aug; 74(4):1212-6. PubMed ID: 8055440
    [No Abstract]   [Full Text] [Related]  

  • 9. Mammography utilization, public health impact, and cost-effectiveness in the United States.
    White E; Urban N; Taylor V
    Annu Rev Public Health; 1993; 14():605-33. PubMed ID: 8323604
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for breast cancer.
    Fletcher SW; Black W; Harris R; Rimer BK; Shapiro S
    J Natl Cancer Inst; 1994 Apr; 86(7):558-61. PubMed ID: 8133541
    [No Abstract]   [Full Text] [Related]  

  • 11. Summaries for patients. Screening for breast cancer: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2002 Sep; 137(5 Part 1):I47. PubMed ID: 12204048
    [No Abstract]   [Full Text] [Related]  

  • 12. Dangers and unreliability of mammography: breast examination is a safe, effective, and practical alternative.
    Epstein SS; Bertell R; Seaman B
    Int J Health Serv; 2001; 31(3):605-15. PubMed ID: 11562008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective cost-effectiveness analysis of screening mammography.
    Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
    J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening mammography in women 40 to 49 years of age.
    Lisby MD
    Am Fam Physician; 2004 Nov; 70(9):1750-2. PubMed ID: 15554494
    [No Abstract]   [Full Text] [Related]  

  • 16. The National Study of Breast Cancer Screening Protocol for a Canadian Randomized Controlled trial of screening for breast cancer in women.
    Miller AB; Howe GR; Wall C
    Clin Invest Med; 1981; 4(3-4):227-58. PubMed ID: 6802546
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening mammography for women under 50: considerations for fully informed decision making.
    Ernster VL
    Womens Health; 1996; 2(4):257-60; discussion 261-6. PubMed ID: 9453858
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast cancer screening.
    Overmoyer B
    Med Clin North Am; 1999 Nov; 83(6):1443-66, vi-vii. PubMed ID: 10584602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns about recommending routine screening mammograms for women aged 40-49 years.
    Paykel J; Wolberg WH
    J Natl Cancer Inst; 1997 Jun; 89(12):889. PubMed ID: 9196257
    [No Abstract]   [Full Text] [Related]  

  • 20. NCI reverses one expert panel, sides with another.
    Taubes G
    Science; 1997 Apr; 276(5309):27-8. PubMed ID: 9122702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.